Old Web
English
Sign In
Acemap
>
authorDetail
>
Silvia Santisteban
Silvia Santisteban
Eli Lilly and Company
Ixekizumab
Medicine
Internal medicine
Placebo
Immunology
2
Papers
92
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo–Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors
2019
Arthritis & Rheumatism
Atul Deodhar
Denis Poddubnyy
César Pacheco-Tena
Carlo Salvarani
Eric Lespessailles
Proton Rahman
Pentti Järvinen
Juan Sanchez‐Burson
Karl Gaffney
Eun-Bong Lee
Eswar Krishnan
Silvia Santisteban
Xiaoqi Li
Fangyi Zhao
Hilde Carlier
John D. Reveille
Show All
Source
Cite
Save
Citations (90)
FRI0400 LONG-TERM SAFETY OF IXEKIZUMAB IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS/ANKYLOSING SPONDYLITIS: AN INTEGRATED ANALYSIS OF COAST-V AND COAST-W
2019
Annals of the Rheumatic Diseases
Helena Marzo-Ortega
Eduardo Mysler
Tetsuya Tomita
Jeffrey R Lisse
Silvia Santisteban
Sandra Garces
Wen Xu
Martin Rudwaleit
Carlo Salvarani
Sergio Schwartzman
Show All
Source
Cite
Save
Citations (2)
1